drugset / Trial / NCT00136968

Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy

NCT00136968

Phase 1 Completed 12 enrolled Pfizer Mclean Hospital · collab
Non-randomizedSingle-groupOpen-label

Summary

The purpose of this study is to determine the amount of voriconazole in the brain by fluorine-magnetic resonance spectroscopy (MRS) and to compare brain levels to plasma levels.

Timeline

Start
2005-04
Primary completion
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Voriconazole Small molecule